Orbsen Therapeutics is a company that specializes in the development of regenerative medicine therapies. It develops a technology that permits the isolation of stromal cells from human tissue and a range of other species. The company focuses on diabetic foot ulcers, acute respiratory distress syndrome (ARDS), diabetic kidney disease (DKD) and primary sclerosing cholangitis (PSC).